Here is the link to a very good news for SRUTF shareholders in my opinion. They own very important paten regarding THC in beverages and if US finalizes marijuana decriminalization, their patent should become very hot commodity.
https://www.cnn.com/2022/10/06/politics/marijuana-decriminalization-white-house-joe-biden/index.html

Just yesterday wondering same. We must wait next for Sproutly Canada, Inc. to settle its Management Cease Trade Order divestiture sales of Toronto Herbal Remedies and Sproutly, Inc. that owns the Toronto Herbal Remedies shares. Who is buying?, I'd like to know. Is it Sen and/or his friends or associates such that there could be a conflict of interest with appearance that Sen is running down Sproulty Canada to then purchase its subsidiary assets?

Disappointing to have Toronto Herbal Remedies divested from Sproutly Canada, Inc. that with loss of Toronto Herbal Remedies Sproutly Canada, Inc. loses its Canadian research license.
https://www.otcmarkets.com/stock/SRUTF/news/Sproutly-Receives-Research-License-from-Heath-Canada?id=352285

-----

Sproutly Provides Update Regarding Management Cease Trade Order
https://www.otcmarkets.com/stock/SRUTF/news/Sproutly-Provides-Update-Regarding-Management-Cease-Trade-Order?id=367079

Sproutly on June 29th, 2022 entered into court appointed Management Cease Trade Order to divest its ownership of Toronto Herbal Remedies and Sproutly, Inc. that owns the Toronto Herbal Remedies shares.

The Sproutly Canada, Inc. Cease Trade Order was reported by Sproutly as expected to be completed by August 28th, 2022, where also Sproutly Canada Inc.'s audited annual financial report filing for the year ending Feb. 28th, 2022 is about to be released.

Yes, it's Sept 3rd, and again Sen and company are late.

Announcements are expected soon.


Sen previously had Sproutly Canada, Inc. purchase Cannahive, but Sproutly became over extended, thus now selling THR and Sproutly, inc. Seems Sen is not a great business manager. I hope Sproutly operations (Cannahive in particular) are not negatively impacted by Sen other Sproutly lack of management.

Sproutly Canada, Inc. still has its Canadian sales license, its very unique APP technology that by patented extraction methodology creates edibles and beverages with whole flower quick onset, reliable timed MJ experience, has CannaHive and its state of the art high frequency efficient cost-lowering CannaHive production, packaging, and marketing technology and knowhow, and has aligned and deepened working relationship for design manufacture and production of MJ beverages with Kingston Cannabis and Kingston Aluminum (canned MJ beverages).

Sproutly Canada, Inc. will become seller, licenser, packer, distributor of edibles, beverages, and licensed technology, to streamline into singular product/marketing/sales/licensing focused company. Research will no longer be within Sproutly's business model.

I wonder if Sen and Sproutly Canada, Inc. will still partner and align with Toronto Herbal Remedies, that to me always seemed to be close to Sen's essence of approach, innovation, and outlook.

Sen releasing Toronto Herbal Remedies (if not in fact being purchased from Sproutly Canada by Arup Sen) seems may be his sobering and business maturing . Sproutly will be better streamlined.

The sales of Toronto Herbal Remedies and Sproutly, Inc. will improve Sproutly Canada, Inc.'s financials, and likely increase the company's value and value proposition by its efficiencies..

I'm hopeful though wonder if Sen has the moxy and focus to move Sproutly to real production and significant Sproutly presence in the various global MJ marketplaces.

I am excited to see developments with Cannahive technology along with APP technology, and Sproutly and Kingston's beverage releases and sales.

My sense Sen has also been waiting for general and overall broader market acceptance of marijuana, especially in the United States, but then I also wonder what outlook and plans, if any, Sen and Sproutly mngt see, expect, and anticipate specific for Sproutly in the U.S. marketplace. It will happen here in the U.S. (marijuana legalization), but when already?

I often think Sen has the dreams, and understands the interconnections of the MJ movement, but in practice is then another matter. He may be realizing he actually cannot just wait for the perfect timing, but that (better and actual) movement of action is needed in the here and now in order to realize his envissioned outcomes.

I think $SRUTF is very very inexpensive right now. Very beat-up down trodden stock. It looks like a solid bottoming is occurring now. The company has many ducks in a row, pending its action and its substantial actualization in and into the marketplace.

$SRUTF = a buy

.

A month out from last post... Current thoughts?

I've been accumulating all the way down.
Sale of Toronto Herbal Remedies is not cool, but Sproutly with Cannahive assets for production and packaging in-house, deals with Kingston for beverages and edibles, and CEO Sen now sobering from being high all the time, Sproutly will turn around and sales are going to happen as very very likely. Under $4M marketcap is wildly inexpensive. Buy when cheap and hated and if in disarray with positive outcome very and most likely. Good luck. sio

CEO Dr. Arup Sen, if you are reading this, please know all us long-term investors appear to now believe you are a cunt of the highest order. Bad Karma is heading your way, bitch.

https://catchingnews.com/2022/04/22/sproutly-canada-srutf-stock-jumped-22-on-friday-why/

Hey thanks! Main Canadian symbol is SPR.CA.
No daily gaps on the main Canadian chart compared to SRUTF as the U.S. OTC equivalent.
SPR.CA big weekly move from oversold 25 to 64.
I'm thinking most the bids (sell trades) were buyers being filled at the bid, a decent floor being put in, as the price kept rising even on all the 'selling volume'. 10 Factor is 10X the daily money volume.
Further, SPR.CA and SRUTF closed at highs of the week, above daily and weekly 20 day Bollinger Bands.

If this is a trend reversal, then SRUTF $0.08 to $0.11 USD may be on tap In the short term, which on the SPR.CA is $0.10 to $0.14 CAD.

Good luck!

#DDAmanda Chart on: $SRUTF :

You can scan for these before they run.



What the Fact (Factor) Column is:

The Factor is a proprietary indicator used for scanning in #DDAmanda.

It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

That's significant, and many times indicates that a run in the stock is coming.

Sproutly Announces Expanded Relationship with Kingston Cannabis Inc.

VANCOUVER, BC, April 18, 2022 /CNW/ - Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), announces that it is expanding its commercial relationship with Kingston Cannabis Inc. ("KCI"), a Health Canada Licensed processor.

Sproutly and KCI have agreed to form a joint venture ("JV") that will utilize the proprietary APP technology to produce proprietary, natural, whole plant extracts of cannabis and hemp which will be used to formulate, evaluate, manufacture, and sell beverage and edible products. Sproutly will grant the JV a license to use the APP technology to produce and sell the products in Canada and Australia, and may elect to expand to other countries in which Sproutly has exclusive rights to the APP technology. KCI will provide the licensed facility and operating services to the JV while Sproutly will provide the APP license, technical services and oversight. The parties will utilize the JV to jointly develop brands, market products, and share in JV profits. Sproutly retains the rights to grant APP licenses to other licensed producers and KCI retains the right to produce and sell other products that do not use the APP technology. APP processing operations are being set up at KCI allowing the JV to produce the extracts and finished products at the same site in order to minimize the cost to produce.

"Expanding the scope of the existing Sproutly-KCI relationship with this JV is a show of our successful collaboration in formulating and evaluating beverages using APP extracts. The JV will now integrate APP processing and finished product manufacturing to avoid potential issues that arise from divided manufacturing and avoid duplication of some operational expenses", said Arup Sen, CEO and director of Sproutly. "We can now offer prospective partners a fully integrated flower-to-finished product service." he added.

"We are harmonizing our operations to move in stride and release next generation botanical products and packaging that will shape medicine and technology. Our combined work, detailed research, and significant experience will be critical to establishing growth within local cannabis markets as well as international medical avenues. We are excited to welcome these new ideas to fruition and materialize a successful future with our partners." Said Jonathan Pilon, President of KCI.

About Sproutly Canada, Inc.
Sproutly is the exclusive licensee of APP technology (www.infusionbiosciences.com) to produce proprietary natural water-soluble Infuz2O and BioNatural Oils. Beverage and edible products produced using the whole plant extracts will deliver true to strain whole plant experiences to new consumers and cannabis connoisseurs alike, ushering in the Cannabis 3.0 revolution. Sproutly intends to enter into partnerships with established companies and consumer brands to market unique products that deliver cannabis and hemp whole plant experience and health and wellness benefits, in major commercial territories around the world.

For more information on Sproutly, please visit: www.sproutly.ca.

About Kingston Cannabis Inc.
Kingston Cannabis Inc. operates a licensed cannabis processing facility that creates high end cannabis-infused beverages, edibles, and capsules featuring recyclable metal containers. KCI harnesses the significant experience of its co-founder in the cannabis and homeopathic markets, as well as the expertise of its partnerinproducing unique, eco-friendly, world-leading aluminum packaging. KCI has significant international connections to world cannabis markets and works with all aspects of cannabis processing from ginetics to advanced manufacturing.

For more information on KCI, please visit: www.kingstoncannabisinc.ca

Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or believes regarding future events of management of Sproutly. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward-looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things, timing relating to the Company's ability to complete a definitive agreement with KCI and launch Cannabis 2.0 products.

These forward-looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These assumptions, risks and uncertainties include, among other things, the Company's inability to launch or supply its Cannabis 2.0 products in Canada; the Company's inability to complete a definitive agreement with KCI and launch additional products; potential negative consumer, investor or public perception of the additional product lines; changes in consumer preferences and product trends; and political, legal and regulatory uncertainty relating to cannabis products generally. In making the forward looking statements in this news release, the Company has applied several material assumptions, including without limitation, that the Company will launch its Cannabis 2.0 products in Canada; that the Company's products will be positively received by consumers in Canada; and that the Company will continue to develop and launch its Cannabis 2.0 products. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

SOURCE Stone Ridge Exploration


For further information: Dr. Arup Sen, Chief Executive Officer and Director of Sproutly Canada, Inc., Email: investors@sproutly.ca

https://www.newswire.ca/news-releases/sproutly-announces-expanded-relationship-with-kingston-cannabis-inc--809756871.html

Sproutly Receives Research License from Health Canada

VANCOUVER, BC, April 13, 2022 /CNW/ - Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), is pleased to announce that the company's wholly-owned subsidiary, Toronto Herbal Remedies Inc. ("THR"), a licenced producer under the Cannabis Act, has received a research licence from Health Canada effective April 11, 2022. The licence allows THR to evaluate the ingredients produced by the proprietary APP technology and product formulations incorporating these ingredients.

"We are pleased to receive this license since we can now evaluate our proprietary extracts and the unique 2.0 product formulations before moving them forward to manufacturing and sale to Canadian consumers." said Arup Sen, CEO & Director. "We believe it is important to know the sensory characters of the products we market and this license will allow us to further improve upon our beverage and edible product candidates", he added.

About Sproutly Canada, Inc.

Sproutly's core mission is to become the leading supplier to the cannabis beverage and edibles market. Our Toronto based, ACMPR licensed facility was built to cultivate pharmaceutical grade cannabis to supply a technological breakthrough in producing and formulating the first natural, truly water-soluble cannabis solution. Our water-soluble ingredients and our bio-natural oils will deliver revolutionary brands to international markets that are clamouring for well-defined commercial products. Sproutly's business focus is to execute on partnerships with local and globally established consumer brands to leverage their existing customer bases, further expand brand loyalty, assist with marketing, and support distribution networks to deliver this scientific breakthrough with speed and efficiency worldwide.

For more information on Sproutly, please visit: www.sproutly.ca.

Forward-Looking Statements

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or believes regarding future events of management of Sproutly Canada. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward-looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things, the expected launch of the Company's first line of beverage products. These forward-looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These assumptions, risks and uncertainties include, among other things, the Company successfully completing the development and production of its first line of beverage and cannabis products and obtaining all applicable regulatory approvals from global jurisdictions including Health Canada. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended, such as the Company's inability to successfully develop and produce its first line of beverage products or the Company's inability to obtain any necessary regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

SOURCE Stone Ridge Exploration


For further information: Arup Sen, Chief Executive Officer of Sproutly Canada, Email: investors@sproutly.ca

https://www.newswire.ca/news-releases/sproutly-receives-research-license-from-heath-canada-888390888.html

It's coming. Does seem progress is occurring. Seems Sproutly and Kingstron have done some product development and testing. And now their Joint Venture. Sen very intent to 'get it right' the first time before entering the market with beverages and edibles. I'm sure curious how that Cannhive acquisition is being incorporated.

Today's close of SRUTF is a major arbitrage opportunity for those buying at U.S. $0.03. SRU closed today at CAD $0.05, that based upon today's CAD to USD rate makes SRUTF valued at $0.0398. And yet SRUTF closed 25% lower at $0.03.

SRUTF just may gap again tomorrow due to currency arbitrage, separate U.S. trading from SRU, and in aligning with parent Canadian stock SRU, that closed at its highs today on increasing higher volume.

Nice buy at that price! Still have high hopes and expectations for Dr Sen to leverage his pioneering technology! He owes us Longs way more than he is providing as our CEO.

That bottom $0.0163 was me buying. Go Sproutly!

No daily gaps on the SRU main Canadian stock for Sproutly. Increasing daily volume too.

I'm up to 1/2 million shares now. Green on all.

MarketMakers are taking this down. Seems MM-are-themselves the shorts.

Just 444 shares at $0.018, that was 8.163% below the highest bid price of $0.0196.

These 'legitimate' market makers are illegitimately driving the Sproutly share price down. They also change the tape to remove trades and ticks that occurred, that were on the tape, then later removed altogether. I've seen and experienced it now several times.

I take advantage. I just buy more.

CEO Arup Sen, you must majorly step up your performance as CEO. Wondering if your “special” APP tech actually exists. I will likely report you to the SEC in the coming weeks bar a significant communication to your (gullible?) shareholders from yourself in the meantime.

@StockItOut: Sincerely good luck to you! Active & successful traders of penny stocks need a certain level of technical knowledge & ability and so I think it's fine for these types of day traders/scalpers with solid know-how. But for those like me, who are more long-term investors & who do not have time to day trade nor the technical knowledge, I wanted to share my experience, perspective and lessons learned for those that might be on the fence, lost and confused. I've sold about half so far and have already invested in stock that are gaining faster than SRUTF, meaning I've recouped some of the loss on SRUTF on another stock already. About 70% of my investment are allocated for long-term with successful, more stable companies and 30% continue to be on more risky stocks but I am 1000% more decisive on my short-term play where I will buy/sell in matter of weeks if it doesn't move to the upside (still requires a lot of time and learning to have a sense to when to enter, when to sell regardless of a gain or a LOSS). Really, I wish everyone and good luck to you. Again, the oldest trick to pump and dump is "patent pending" that never materializes and the loans and payoffs between 2 companies controlled by one-person is another classic way to siphon $ from one paper entity to another while being able to claim a huge loss/tax write-off. Really good luck to you!

Well thanks. I assure you I'm real, not trading this, have 300,000 shares. But I'm in at these current prices, not experiencing under water as you and 'half-full' express you are, which is a very different psychology, I understand.

SRUTF fairly recently ran up 300%. I held, sure would have been great to have sold while ip 300% and reacquire at current prices, but I round tripped it. I expect it to do it again (3X) at some point relatively easily too, and likely beyond much higher, whether on the next rise I cannot say. Sproutly marketcap is very low. I think the 'whole flower' approach is novel and very strong, what Sen refers to as Cannabis 3.0 (which I think is a stupid dry sizzle negating way to refer to it). Gummies, drinks coming, and soon, Cannhive, Kingston,, Infuz2O licensing to other beverage makers, quick on-set, consistent timed off-set, and whole plant uniqueness, benefits, experience, health even, I like it.

I'm retail, not a MM, not with Sen, not trading this. I expect to hold for years.

Things are happening with Sproutly.

I don't see mngt stock shenanegans. In fact I consider it a positive that Infuse BioSciences (which is Sen) loans Sproutly money and allows Sproutly to payoff loans with stock. Sproutly does not have wild if any debt.

Watch this mfer, it's going to go.

If you guys sell and drive this to $0.01, I'm gonna load up!

By the way, while back my broker contacted me because of my large share count, and offered I provide my shares for the active short market on SRUTF, where they's pay me a pretty nice premium. A thinly traded stock is easily manipulable by the Market Makers. I've watched these crooks literally cancel sales, ticks on the tape, that minutes later are gone. All my broker trade desk said was he could only see what was on the tape. yeah...

@half-full: It's been a struggle getting rid of it myself as there are zero buyers. Since 2018, I've done a ton of learning...any stock with "pending patent," "pending FDA approval" learned that it's best to stay away and tend to be ripe with fraudsters. And once it starts tanking, no matter how painful it is and how dreamy it is to hold on "to the dream" one has to be decisive and cut their losses and move on. I paid $36K USD for this lesson. LOL. I'm grateful for the lesson in a way because I am a far better investor now, but I do feel horrible for any true believers on this board, if there are any. I think most that are positive about this stock are the penny traders that do daily scalping and/or Dr. Sen&his team who are using the same tactic to keep the milking machine going as long as they can. Good luck to you!

Sproutly CEO has done a few interviews lately and you can find them on YouTube. Worth watching them. I too am holding a very expensive bag since about 3 years now too but am no way dumping at this point given the business is finally developing. I regard this as a very slow burn but will hopefully pay off with time. Dr Sen should address shareholders for sure. GL.

Eohhoman, Lack of any substantive progress has done it for me. I also purchased way to much early on and am now having a difficult time getting out. It took me over 3 weeks to get a 200,000 share order filled at .04 US. Nobody wants the shares. I'm getting ready to try and get rid of the rest.

Wow, seeing your post made me feel better. I have been planning on finally dumping come December but wanted to check if there are still die-hard believers of SRUTF...not sure if it's real people for folks at the company or penny stock traders who are posing as die hard believers of SRUTF. In the end it doesn't matter for me. But I've put in $36K USD back in 2018 and held all this time and it's good to know that I am not the only dummy who did something so reckless & dumb. I am finally facing facts -- 1. apparently it's the oldest trick to say there is an "an advanced tehnological pending patent" that will never materialize ever to pump and dump stocks; 2. there is too much competition in the pot space; 3. illegal market continues thrive even better now; and 4. even if approval happens the laws & regs will be too cumbersome hindering profit potential. Dumping all by end of year but I am watching for the year-end rally, which I'm doubtful of. Good luck penny stock traders, may your pump & dump efforts payoff!

new presentation
https://sproutly.ca/wp-content/uploads/2021/10/SPR_Corp_Pres_102021.pdf

"Complete." Wow, from you a compliment, considering your expertise in bullshit.

Oh you bet it is!!!

It’s all coming together ??

Wow!!!! Talk about complete BULLSHIT!!!! lolzzzzzzzz

This will break above 10X in time, I expect. Wildly undervalued here.
I have been interested in Sproutly for years. Watched and waited. Bought at bottom. Waited... waited. Then 3X higher move. Held. Back to just above bottom. Waiting, and nice to see developments as expected.
I like Sen's philosophy of 'get it right' as he's a long term spiral movement scientist creator.
I like the alignment with Kingston.
Cannahive good yoo, and then, 'why not buy them' win-win. The industry in consolidating quickly, and Sen understands Sproutly's niche. And Sproutly's organic ability to alter the market.

I would say we are seeing true progress for the first time since the big Moosehead deal (that almost materialized). It has been slow and painful to be a long term investor - especially for those who paid 10x current PPS - so I would say the number of shares to hold or increase depends on your average PPS. How much sense does it make to average down? And how much confidence do you have in Dr Sen to finally execute? I have invested approx. $50,000 USD to date. GL.

I like this company.

Is 300,000 shares enough at these value depressed prices?

BEVERAGES, finally.....!
Oct 07, 2021 (Investor Brand Network via COMTEX) -- Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) today announced its entry into a letter of intent ("LOI") for the formation of a commercial relationship with Kingston Cannabis Inc. ("KCI"), a Health Canada licensed producer, to launch its cannabis-infused beverages through a co-packing arrangement with KCI. Under the arrangement, KCI's affiliate, Kingston Aluminum Technologies Inc. ("KAT") will provide custom designed aluminum packaging for Sproutly's products. In addition, KCI and Sproutly will collaborate on the consumer evaluation of Sproutly's formulations made using ingredients produced by the proprietary APP cannabis processing technology. "This relationship will allow us to launch our beverages made with our proprietary Infuz2O extract in distinct, environmentally friendly aluminum containers with unique internal coating for better preservation of cannabis products," said Dr. Arup Sen, CEO and director of Sproutly. "Additionally, we will utilize KCI's research license to test our product formulations and select our 3.0 beverages for features that are preferred in consumer products that will deliver a true-to-strain, whole-plant experience."

To view the full press release, visit https://cnw.fm/DWB9b

Still promoting this SCAM? lolzzzzzzzzz

"This SCAM is going sub-penny" is like a dog pissing at a fire hydrant, then a wall, then a bush, back to the hydrant...

This SCAM is going sub-penny! lolzzzzzz

They did just acquire another company. A good one.
Sen showed two Sproutly drinks yet to be released.
New alignment with Kingston.

I would prefer news releases that contained some actual information and not just fluff.
I do agree with you that there is enough happening, though extremely slowly, that it is worth waiting to see how things go. It has to be soon though, because I don't see it being possible for the company to continue financing it's existence by diluting our ownership by paying off loans with shares. Each time this has been done, we have not only lost a share of future earnings, but our share price has dropped as the newly issued shares get dumped on the market.

Thanks for the reply though. Your obviously not blind to the risk, or the frustration and your right to hope for the best.

Yes. I was actually surprised that the latest news was not the gummie sale. Hopefully they do get that going soon to bring in some revenue.

I was thinking earlier today that I would like to see more licensing of the technology. This allows the execution of bringing products to market into some other companies hands that may be a bit more timely, but also allows Sproutly to benefit financially.

I agree, it is not a contract, a non-binding agreement.but is a step towards using the APP process. would you rather there was no LOI? flag trading recently released their hash coin through Sproutly's licence which means some revenue will be coming.Toronto herbal remidies (a Sproutly subsidiary) will soon be producing gummies and such. as for when the sproutly/kci beverages will be ready the NR stated first quarter of 22, although considering the success of past time lines I would not be terribly surprised to see that slip. In any case it is enough to keep me in the game and maybe increase my share holdings. P.S. and of course I'm still have hope of Moosehead finally getting in the game.

They did say gummies sales Q4. Let's see...

They did license infuz20 to a new york beverage company.

those who have lost all hope should just take their loss and move on

Gee, I never thought about selling.

My biggest problem is that they are giving me no reason to keep buying! If I don't want to buy any, who does? If nobody wants to buy, what do you think happens next?

success is just around the corner

Have I missed something? What success are you referring to? Kingston? Just what is your idea of a time frame till distribution? All they have so far is a letter of intent. Just a non-binding agreement. Not a contract. It doesn't get much more preliminary than this.

sure cannot blame anyone for being upset at the very slow progress Sproutly has made. but things are starting to look up. kingston cannabis being the latest good news. been invested for 2+ years and have been very frustrated but with the latest news over the past couple of months I am greatly encouraged and intent to continue to stay around as success is just around the corner. of course those who have lost all hope should just take their loss and move on to something else. but don't look back as the only thing worse than losing on a stock is selling that loser and watching it have wild success. GLTU all.

Looks like the SCAM here is exposed.....whoopsie! lolzzzzzzzz

Patience? And then you post a two year old article. Hahaha
Forgive me for not getting excited and investing more into this.

That is the problem. The company has not executed on anything in two years and there are now no buyers left to prop up the stock that they have been using as a piggy bank to pay themselves.
Even the scheme of paying bills with shares is about to come to an end. This last distribution is hanging heavy and it is now to the point that even if positive news is released, there is no credibility left to drive the price up again.
The only thing that would help now would be multiple quarters of increasing revenue according to 8k and 10k filings. Nothing else is believable anymore. Unfortunately, this doesn't seem realistic at this point. The opportunity has past.

2-years' news: Technological Innovation Pushes Bounds of Edible Cannabis Market
September 11 2019 - 08:45AM
NetworkNewsWire

CannabisNewsWire Editorial Coverage: A desire to move away from smoking may be fueling growth in the edible cannabis products.

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (SRUTF Profile) is developing new technology to manufacture cannabis edibles and to accurately measure their active ingredients. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has created a bold new technology to make cannabis’ active ingredients more palatable and absorbable. BevCanna Enterprises Inc. (CSE: BEV) (OTC: BVNNF) is producing white-label products, giving other brands access to the market. HEXO Corp. (TSX: HEXO) (NYSE: HEXO) is meeting its regulatory needs by acquiring other licensed cannabis producers and processors. Valens GroWorks Corp. (TSX.V: VGW) (OTCQX: VGWCF) has created a large and growing extraction and testing facility.

Cannabis in food and drink offers both health and social advantages over smoking.
The market’s growth depends upon meeting the standards of regulators.
Market growth is driving innovation not just in the production of edible cannabis but also in the technology to measure contents.
To view an infographic of this editorial, click here.

Expanding the Bounds of Cannabis

As the legal boundaries of the North American cannabis industry expand, businesses are looking for ways to make the most of their products and reach the widest possible market. This quest has led to a growing shift in focus away from smoking, which is accompanied by significant health concerns and social challenges. Instead, companies are increasingly focused on alternatives such as edible cannabis products.

The growing demand presents challenges. One of the most obvious is developing the technology to effectively extract the active ingredients in cannabis and incorporate them into foods, drinks, vaping oils and other products. In addition, meeting regulatory standards is also a factor, as authorities move to set standards for a newly legalized industry. Meeting such standards means improving control over products, which in turn means improving measurement systems. And that means developing the technology to do the measuring.

The Advantages of Edible Cannabis

Edibles are quickly becoming an important focus for the cannabis market. Some companies are offering edibles, including beverages, as part of a wider product line, creating cannabis-infused drinks alongside wider beverage lines or more diverse cannabis products. Other companies have narrowed their focus to either cannabis edibles or cannabis-infused drinks. For Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G), the focus is on supplying water-soluble cannabis solutions and bionatural oils to be used in the beverages and consumables market.

The shift toward edibles is a direct response to the decrease in smoking. Cannabis legalization has arrived just as tobacco smoking is seeing a steep decline. Both the percentage of people who smoke and the number of cigarettes they consume each day are going down. Many people who are interested in cannabis, whether for medical or recreational reasons, don’t want to take up smoking. If the cannabis industry is to grow, it appears the most effective way may be to find other ways to reach these potential consumers.

Beverages may be one of the most promising ways to replace smoking as the leading form of cannabis consumption; this trend should provide growing business opportunities for companies such as Sproutly. Cannabis-infused beverages allow consumers to choose between alcohol and cannabis on a night out, with users of each able to enjoy the same social setting together.

The downside of this choice is that ingested cannabis typically takes longer to kick in than either alcohol or smoking, disrupting the social dynamic. Sproutly is working to solve this problem with its innovative Infuz2O technology, which provides faster delivery of the active ingredients in ingested cannabis. For both medical users looking for fast relief and recreational users looking to keep pace with their companions, it’s a potentially valuable step.

Cannabis Regulation and Measurement

Cannabis edibles don’t automatically become legal just because cannabis itself has. For example, a delay was written into Canada’s legalization legislation to give time to prepare regulations for ingestible cannabis products such as those Sproutly supports.

These regulations, like those around smokable cannabis, are created with good reason. Governments need to be able to establish standards for recreational drugs to minimize the risk of harm both to consumers and to others who may be affected by those consuming the products.

One form of regulation that appears certain to make its way from alcohol to cannabis is the need to measure and state the strength of consumer products. Two decades of development mean that the methods for these measurements are fairly well established for smokable cannabis, but ingestible cannabis products raise new challenges — ones that Sproutly subsidiary Infusion Biosciences Inc. is addressing.

The methods currently used for the detection and quantitation of cannabinoids were designed for isolated oils. That means they are unable to accurately and reliably measure cannabinoid contents in finished edible and beverage products, which are significantly more complicated. But under the leadership of Sproutly’s chief science officer, Dr. Arup Sen, Infusion Biosciences has developed analytical methods that measure the cannabinoid molecules in water-soluble and oil preparations created using Sproutly’s APP technology. This development marks a significant step toward accurately testing and labeling the content of cannabis ingestibles.

“The ability to test for cannabinoids in water formulations has been unreliable for cannabis beverages globally due to the existing testing standards and practices,” said Sen. “With ever-increasing food-safety standards that need to be met for cannabis beverage and edible products, the completion of our research and the Developed Analytics are significant milestones in the commercialization of APP Technology; this is another step forward towards reliable and accurate testing for ingestible cannabis products.”

Innovating on All Levels

To successfully develop the market for ingestibles, cannabis companies need to be innovating on every level, from the extraction of active ingredients to their measurement, to the recipes for active foods and drinks. Even the way that cannabis is marketed is going to change as its place in people’s lives changes.

Although it’s unlikely that any company will attack this from every angle, it’s a good sign for the market that so many are taking on multiple interlinked issues at once. This is visible in Sproutly’s approach, with the creation of new technology to both create and measure ingestibles.

Infuz2O is the centerpiece of Sproutly’s work. A water-soluble cannabis liquid that moves away from the need for emulsification or encapsulation, Infuz2O allows the delivery of a precisely measured dose of active ingredients from cannabis in an odorless and easy-to-handle form. The effects of the cannabis are felt within five minutes and wear off within 90 minutes, bringing the experience closer to that of alcohol. This delivery method could make it easier to manage for consumers who are new to cannabis or who want to consume their drinks alongside alcohol drinkers, both important pieces for the beverage market.

By developing Infuz2O alongside its testing technology, Sproutly has given itself a way to test the reliability of its product as well as a product to test the measurements on. The move appears to be both a logical and efficient strategy.

Beyond Weed

Cannabis is moving beyond its old image, where “weed” was a fitting label for something that spread where it wasn’t permitted — something primitively grown and furtively consumed. A plethora of companies are now working to develop sophisticated products for a more sophisticated — and legal — market.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is another innovator in the field of delivery methods. The company’s DehydraTECH(TM) technology uses fatty acids to make cannabinoids both more palatable and easier for the body to absorb. This increases the efficiency of cannabis products as well as removing a challenge to the flavor of ingestibles. Like Sproutly, LXRP is working in close cooperation with the authorities to improve the measurement and understanding of cannabinoids through groundbreaking research with the National Research Council of Canada.

BevCanna Enterprises Inc. (CSE: BEV) (OTC: BVNNF) is innovating within the industry by importing a business model that has seen little use in cannabis — white-label products. BevCanna researches, packages and produces cannabis-infused beverages to appear under the branding of other companies. The approach keeps the company itself out of the public eye while allowing its clients easy access to this new market without having to develop extensive in-house expertise.

Licensing is an essential part of the cannabis regulatory process. Consequently, companies are moving to acquire more licenses to produce and sell cannabinoids. Some are doing this primarily through their own applications, but others, such as HEXO Corp. (TSX: HEXO) (NYSE: HEXO), have been using acquisitions to build up its businesses. A medical cannabis provider that entered the recreational market last year, HEXO has acquired Newstrike, the parent company of Up Cannabis Inc., a licensed producer and distributor. This acquisition should give HEXO a bigger footprint within the profitable Canadian cannabis market, where unmet demand continues to offer great profit potential.

As a growing number of farmers start cultivating cannabis, somebody needs to provide the extraction and testing services to turn the crops into ingredients for ingestibles. Valens GroWorks Corp. (TSX.V: VGW) (OTCQX: VGWCF) provides extraction and testing services. The company uses a variety of extraction methods to obtain the active ingredients from cannabis crops, producing extracts ideally suited for the products they will be used in. This summer, Valens announced that its extraction capacity had reached 425,000 kg per year, with plans to reach more than a million kilograms.

As the cannabis market shifts towards edible products, extraction and testing work, along with the innovative technology driving it, may become a linchpin of the cannabis economy.

For more information on Sproutly Canada, visit Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.



Source:

CannabisNewsWire


Contact:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net


https://ih.advfn.com/stock-market/USOTC/sproutly-canada-qb-SRUTF/stock-news/80707473/technological-innovation-pushes-bounds-of-edible-c

Patience grasshapah. Get to know Kingston.

I do in fact share your frustration and sense of relative pessimism - particularly as I have close to $50,000 invested in Sproutly.
CEO Dr Arup Sen has thus far failed to deliver anything of acceptable significance to shareholders.
He and his legacy will either be left in tatters or he will step up and commit to finally delivering albeit at what seems to be snail pace so-to-speak.
GL (we will very likely need it).

Sproutly enters LOI with Kingston Cannabis

Letter of Intent, since they never bothered to define it in the article.

So what does this mean? I would guess about two more years of working out the details, testing, re-testing, reformulating, re-testing, and so on.

What happened to all the gummies? Still nothing? Are they just sitting there rotting away?

It's a bit difficult to support this company when they pay their bills by trading shares for money. Every day we get to watch as a hundred thousand shares are listed for sale at lower and lower price, while nobody is interested in buying.

Bad decision to buy into this one, and too late to get out.

Not quite the news we had hoped for, but certainly staying true to form.

Sproutly Announces Shares for Debt Settlement
BUSINESS WIRE 9:56 AM ET 9/16/2021
Symbol Last Price Change
SRUTF 0.0439up +0.0005 (+1.152074%)
QUOTES AS OF 09:57:19 AM ET 09/16/2021
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Sproutly Canada, Inc.(SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) announces that it intends to settle outstanding current debt (the “Debt Settlement”) of the Company and the Company’s subsidiary, Toronto Herbal Remedies Inc., in the aggregate amount of $145,448.44 (the “Debt”), pursuant to the terms of debt settlement agreements with two arm’s length creditors (the “Creditors”). In settlement of the Debt, the Company has agreed to issue an aggregate of 2,908,968 common shares in the capital of the Company (the “Settlement Shares”) at a price of $0.05 per Settlement Share.

The Debt will be extinguished upon the issuance of the Settlement Shares. The Creditors voluntarily elected to satisfy their respective Debt with the Settlement Shares in lieu of cash payment, which will allow the Company to preserve its cash for future operations.

All securities issued in connection with the Debt Settlement will be subject to a four-month and one day hold period from their date of issue under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.

Is you hoodie keeping you warm during the mindmed freeze over?

Incorrect. There is revenue and it will increase incrementally hereon. This has been a very slow launch however the tech is still brilliant so let’s see what Sen can do with it.